Duan, Y.; Lanzillotti, M.; Riggs, D.L.; Nito, A.; Mijares, J.; Helms, A.; Ly, C.; Millea, K.; Li, X.; Zhang, H.;
et al. Artificial Oxidation: A Major Challenge in Implementing Multi-Attribute Methods for Therapeutic Protein Analysis. Pharmaceuticals 2026, 19, 528.
https://doi.org/10.3390/ph19040528
AMA Style
Duan Y, Lanzillotti M, Riggs DL, Nito A, Mijares J, Helms A, Ly C, Millea K, Li X, Zhang H,
et al. Artificial Oxidation: A Major Challenge in Implementing Multi-Attribute Methods for Therapeutic Protein Analysis. Pharmaceuticals. 2026; 19(4):528.
https://doi.org/10.3390/ph19040528
Chicago/Turabian Style
Duan, Yaokai, Michael Lanzillotti, Dylan L. Riggs, Albana Nito, Junnichi Mijares, Amanda Helms, Carl Ly, Kevin Millea, Xingwen Li, Hao Zhang,
and et al. 2026. "Artificial Oxidation: A Major Challenge in Implementing Multi-Attribute Methods for Therapeutic Protein Analysis" Pharmaceuticals 19, no. 4: 528.
https://doi.org/10.3390/ph19040528
APA Style
Duan, Y., Lanzillotti, M., Riggs, D. L., Nito, A., Mijares, J., Helms, A., Ly, C., Millea, K., Li, X., Zhang, H., & Zhang, Z.
(2026). Artificial Oxidation: A Major Challenge in Implementing Multi-Attribute Methods for Therapeutic Protein Analysis. Pharmaceuticals, 19(4), 528.
https://doi.org/10.3390/ph19040528
